fundvisualizer.com

Morgan Stanley Inst EMkts Ldrs IMELIX

Performance (before sales charge)

As of 12/31/2022

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 09/30/2022
Stock
7.51%
Non-U.S. Stock
87.25%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
5.24%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 09/30/2022

Basic materials

5.03%

Consumer cyclical

24.03%

Financial services

27.70%

Real estate

0.00%

Consumer defensive

9.25%

Health care

0.00%

Utilities

0.00%

Communication services

0.00%

Energy

0.00%

Industrials

8.38%

Technology

20.38%

Top 10 holdings

As of 09/30/2022

Bajaj Finance Ltd
7.89%
MercadoLibre Inc
7.69%
Li Ning Co Ltd
6.41%
ICICI Bank Ltd
5.66%
Globant SA
5.65%
Morgan Stanley Instl Lqudty Govt Ptcpt
5.23%
Aarti Industries Ltd
4.96%
AU Small Finance Bank Ltd
4.85%
Proya Cosmetics Co Ltd Class A
4.29%
Shenzhou International Group Holdings Ltd
3.93%
Fund assets

$284.24 Million

Share class

Inst

Morningstar category

Diversified Emerging Mkts

Expense ratio

1.05%

Investment objective

Diversified Emerging Markets

Documents